Cite Filings / XFOR / 0000932471-25-000265

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

X4 Pharmaceuticals, Inc Filed 2025-01-31 Acc 0000932471-25-000265

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-07-18 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-01-31 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-01-27 4 President and CEO sold 76,473 shares at $0.45 ($34,719)
2025-01-27 4 Chief Financial Officer sold 74,773 shares at $0.45 ($33,947)
2025-01-27 4 Chief Commercial Officer sold 29,159 shares at $0.45 ($13,241)
2025-01-27 4 Chief Operating Officer sold 22,258 shares at $0.45 ($10,094)
2025-01-27 4 Chief Medical Officer sold 11,624 shares at $0.45 ($5,284)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…